A2 Refereed review article in a scientific journal 
A pharmaceutical model for the molecular evolution of microbial natural products
Authors: David P. Fewer, Mikko Metsä‐Ketelä
Publisher: Wiley-Blackwell
Publication year: 2019
Journal:FEBS Journal
Journal acronym: FEBS J
Volume: 287
First page : 1429
Last page: 1449
Number of pages: 21
ISSN: 1742-464X
eISSN: 1742-4658
DOI: https://doi.org/10.1111/febs.15129
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/44154216
Microbes are talented chemists with the ability to generate tremendously
 complex and diverse natural products which harbor potent biological 
activities. Natural products are produced using sets of specialized 
biosynthetic enzymes encoded by secondary metabolism pathways. Here, we 
present a two‐step evolutionary model to explain the diversification of 
biosynthetic pathways that account for the proliferation of these 
molecules. We argue that the appearance of natural product families has 
been a slow and infrequent process. The first step led to the original 
emergence of bioactive molecules and different classes of natural 
products. However, much of the chemical diversity observed today has 
resulted from the endless modification of the ancestral biosynthetic 
pathways. The second step rapidly modulates the pre‐existing biological 
activities to increase their potency and to adapt to changing 
environmental conditions. We highlight the importance of enzyme 
promiscuity in this process, as it facilitates both the incorporation of
 horizontally transferred genes into secondary metabolic pathways and 
the functional differentiation of proteins to catalyze novel chemistry. 
We provide examples where single point mutations or recombination events
 have been sufficient for new enzymatic activities to emerge. A unique 
feature in the evolution of microbial secondary metabolism is that gene 
duplication is not essential but offers opportunities to synthesize more
 complex metabolites. Microbial natural products are highly important 
for the pharmaceutical industry due to their unique bioactivities. 
Therefore, understanding the natural mechanisms leading to the formation
 of diverse metabolic pathways is vital for future attempts to utilize 
synthetic biology for the generation of novel molecules.
| Downloadable publication  This is an electronic reprint of the original article. | 

